• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Ensysce Biosciences Announces Closing of Merger firstwordpharma
    July 01, 2021
    Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ: ENSC) (OTC: ENSCW) today announced that it has closed its previously announced merger with Leisure Acquisition Corp. ("LACQ").
  • “At Home Coronavirus Pill” to Advance to Phase 2 Clinical Development americanpharmaceuticalreview
    May 08, 2021
    Ensysce Biosciences, Inc. announced that Ensysce’s subsidiary, Covistat, will be presenting at the upcoming American Thoracic Society (ATS) Annual Meeting to be held May 14-19, 2021.
  • Recro, Ensysce Expand Development and Manufacturing Partnership contractpharma
    April 16, 2021
    ​Recro Pharma, a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, has signed additional agreements with an existing ...

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service